Nothing in Abbott Laboratories (NYSE:ABT)‘s trading history since 1968 resembles Thursday morning.

A three-cent earnings beat and a narrow guidance raise unlocked the largest single-day advance the stock has ever recorded.

Shares of Abbott Laboratories jumped as much as 13.6% by 9:00 a.m. ET.

What Happened: The company reported second-quarter adjusted earnings of $1.31 per share, above the $1.28 consensus. Sales rose 13% to $12.59 billion, topping estimates near $12.5 billion.

Comparable sales — which strip out currency swings and the Exact Sciences acquisition — grew 4.8%.

Abbott lifted its full-year adjusted earnings guidance to $5.45 to $5.60 per share, from $5.38 to $5.58, and reaffirmed comparable sales growth of 6.5% to 7.5%.

“Our second-quarter results reflect the momentum we are building,” said Robert B. Ford, chairman and chief executive officer.

Why it matters: the bar was on the floor. Prior to Thursday’s rally Abbott shares were down 30% year-to-date, and on May 11 fell as low as $81.97, their weakest since April 2020.

Even after the surge, the stock trades roughly 30% below its December 2021 peak of $141.16.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.